NMTC Oct 2024 2.500 call
| Previous Close | 0.2500 |
| Open | 0.2500 |
| Bid | 0.3000 |
| Ask | 0.7000 |
| Strike | 2.50 |
| Expire Date | 2024-10-18 |
| Day's Range | 0.2500 - 0.2500 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 50 |
Simply Wall St.Favourable Signals For NeuroOne Medical Technologies: Numerous Insiders Acquired Stock
Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...
GlobeNewswireNeuroOne® CEO Dave Rosa Featured on Bloomberg Technology
EDEN PRAIRIE, Minn., April 10, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announces an appearance by Chief Executive Officer Dave Rosa on Bloomberg Television's Bloomberg Technology. A replay of the segment, which aired live yesterday, can be viewed at NeuroOne-Bloomberg. In conversation with
- GlobeNewswire
NeuroOne® Announces First Implant of OneRF™ Ablation Electrodes
First to market FDA-cleared thin-film, sEEG-guided RF system capable of both recording electrical activity and ablating nervous tissue with the added benefit of temperature control EDEN PRAIRIE, Minn., April 09, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced the first implant of i
